Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

 

BNN Market Call

Three top stock picks from BMO Nesbitt Burns’ Stuart Hinshelwood Add to ...

Stuart Hinshelwood is U.S. Equities Specialist at BMO Nesbitt Burns.

Top Picks:

Abbott Labs

  • Good valuation for EBITDA growth for a diversified health-care stock;
  • upside from Nutritionals, Pharma, Devices & Vascular following spin-off of Abbvie (ABBV) – mostly branded drugs. Upside to $42 (U.S.) ~20 per cent

Franklin Resources

More Related to this Story

  • High-quality asset manager (Templeton, Franklin & Bissett) for a decent valuation.
  • 55-per-cent equity and strong performance in Templeton Global Bond with lower duration and limited U.S. government exposure which is under-appreciated by the Street.

Time Warner

  • decent valuation, high FCF and good pure-play content and Time Inc. spin-off all catalysts

Past Picks: June 3, 2013

Allergan
Then: $98.94
Now: $90.99
Total return: -7.99 per cent

EMC Corp.
Then: $24.74
Now: $26.98
Total return: +9.53 per cent

Target
Then: $71.05
Now: $65.34
Total return: -7.46 per cent

Total return average: -1.97 per cent

Market outlook:

Neutral – with positive bias towards equity (same as June). Recent economic data was not great (i.e. no taper), yesterday`s shot of momentum usually precedes a price peak. U.S. markets are fairly-valued for economic progress. A balanced view overall.

Follow us on Twitter: @GlobeInvestor

 
  • AGN-N
  • EMC-N
  • TGT-N
  • ABT-N
  • BEN-N
  • TWX-N
Live Discussion of AGN on StockTwits
More Discussion on AGN-N
Live Discussion of EMC on StockTwits
More Discussion on EMC-N
Live Discussion of TGT on StockTwits
More Discussion on TGT-N
Live Discussion of ABT on StockTwits
More Discussion on ABT-N
Live Discussion of BEN on StockTwits
More Discussion on BEN-N
Live Discussion of TWX on StockTwits
More Discussion on TWX-N

More Related to this Story

In the know

Most popular video »

Highlights

More from The Globe and Mail

Most Popular Stories